Login to Your Account



Regulatory NEWS

The FDA has published the long-awaited draft guidance for co-development of a therapeutic drug and a companion diagnostic, but the agency has scheduled an Aug. 18 webinar to address questions associated with the draft.

LONDON – The U.S. and U.K. have joined forces in the formation of a public-private partnership to turbocharge early stage antibiotic research and rejuvenate the product pipeline for the next 25 years.

In a solid win for Valeant Pharmaceuticals International Inc., the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted 18-0 in favor of approving the BLA for brodalumab.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: